Thanks for sharing. This moment at the AGM forced me to add even though it’s a full position. If I can paraphrase Prem here: We’re sitting with the bat on our shoulders waiting for fat pitches and virtually every one we have swung on lately has been knocked out of the park.
We should have a rating system based on dollars. If a trade makes $1b it’s a home run like the TRS, duration decisions which allowed for the premium growth and saved billions, the SIB etc..
Right now, I think they are stating plainly that quality compounders on sale is their sweet spot. The beauty of the giant float is that just stacking cash gets them over a 15% ROE. I can see how buying a crash could increase returns and increase the multiple i.e. decrease negative Social Value. Lots of investors won’t buy Fairfax because they only buy quality and Fairfax does not own quality i.e. Fairfax owns stocks they would never buy. Part of Markel’s premium is because they are associated with quality as it’s certainly not because of recent returns. I had a PM friend say FFH’s reputation is as a junk collector but that could change quickly if price changes quickly.
They also seem to have a lot of excess capital. Float is $33b but they have $45b of fixed income. If there is a market dislocation like the pandemic etc… Fairfax might be in the position to deploy 20% or more of its market cap in high quality stocks or the index at a fair price. VOO on the 13F maybe isn’t much of a head scratcher anymore but a capital allocation decision consistent with a new mentality.
Of course, we’ll have to see what they actually do but each fat pitch they swing at could super charge ROE and BV if they get a hit and it seems to me like an environment rich in potential fat pitches including a market dislocation.